Medicine
Tudorza Pressair 400 mcg inhalation powder
Tudorza Pressair 400 mcg inhalation powder is a prescription medicine containing Aclidinium for inhalation use, marketed by Covis Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store TUDORZA PRESSAIR in a dry place at 25°C (77°F), excursions permitted to…
Key facts
- Active ingredient (INN)
- Aclidinium
- Brand
- Tudorza Pressair
- Strength
- 400 mcg
- Dosage form
- Inhalation powder
- Route
- Inhalation
- Packs
- 1 pouch
- Marketing authorisation holder
- Covis Pharma
- Manufacturer
- Covis Pharma
- Origin register
- US FDA, United States
- Storage
- Store TUDORZA PRESSAIR in a dry place at 25°C (77°F), excursions permitted to 15-30°C (59-86°F). Do not store the inhaler on a vibrating surface. The PRESSAIR inhaler should be stored inside the sealed bag and only be opened immediately before use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- R03BB Anticholinergic
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 July 2015
- Identifiers
- RxCUI 1303102, 1303107, 1607111 +1DailyMed set ID 6f92cceb-a63f-4470-99b6-56179d98f10fNDC 70515-002Application NDA202450
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 pouch in 1 carton / 1 inhaler in 1 pouch / 60 powder, metered in 1 inhaler | 70515-002-01 | Covis Pharma | 1 July 2015 |
| 1 pouch in 1 carton / 1 inhaler in 1 pouch / 30 powder, metered in 1 inhaler | 70515-002-02 | Covis Pharma | 1 July 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Aclidinium is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). It is available as inhalation powder. MedsAcross supplies Aclidinium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AclidiniumFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Tudorza Pressair prescribing information (Covis Pharma) · U.S. National Library of Medicine, DailyMed
- Bretaris Genuair: European public assessment report (EPAR) · European Medicines Agency
- Eklira Genuair: European public assessment report (EPAR) · European Medicines Agency
Need Tudorza Pressair 400 mcg inhalation powder for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.